320
Views
29
CrossRef citations to date
0
Altmetric
Review

A review of entecavir in the treatment of chronic hepatitis B infection

Pages 1845-1856 | Accepted 20 Sep 2005, Published online: 13 Oct 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hye Won Lee, Jun Yong Park & Sang Hoon Ahn. (2016) An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults. Expert Review of Gastroenterology & Hepatology 10:2, pages 177-186.
Read now

Articles from other publishers (27)

Guo-Qing Yin, Jun Li, Bei Zhong, Yong-Fong Yang & Mao-Rong Wang. (2021) New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage. World Journal of Gastroenterology 27:8, pages 666-676.
Crossref
Maria Gerasi, Efseveia Frakolaki, Georgios Papadakis, Anna Chalari, Nikolaos Lougiakis, Panagiotis Marakos, Nicole Pouli & Niki Vassilaki. (2020) Design, synthesis and anti-HBV activity evaluation of new substituted imidazo[4,5-b]pyridines. Bioorganic Chemistry 98, pages 103580.
Crossref
Shanshan He, Qing Lin, Mengke Qu, Luyao Wang, Lang Deng, Linyu Xiao, Zhirong Zhang & Ling Zhang. (2018) Liver-Targeted Co-delivery of Entecavir and Glycyrrhetinic Acid Based on Albumin Nanoparticle To Enhance the Accumulation of Entecavir. Molecular Pharmaceutics 15:9, pages 3953-3961.
Crossref
Yanlei Kang, Zhanying Shao, Qiang Wang, Xiurong Hu & Dongdong Yu. (2018) Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy. Journal of Pharmaceutical and Biomedical Analysis 158, pages 28-37.
Crossref
Christos Triantos, Maria Kalafateli, Ioanna Aggeletopoulou, Martha Mandellou, Stelios Assimakopoulos, Paraskevi Tselekouni, Dimitra Taprantzi, Giorgos Tsiaoussis, Georgia Vourli, Evangelos D. Anastassiou, Charalambos Gogos, Chrisoula Labropoulou-Karatza & Konstantinos Thomopoulos. (2017) Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis. European Journal of Gastroenterology & Hepatology 29:9, pages 998-1003.
Crossref
Karel Ulbrich, Kateřina Holá, Vladimir Šubr, Aristides Bakandritsos, Jiří Tuček & Radek Zbořil. (2016) Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies. Chemical Reviews 116:9, pages 5338-5431.
Crossref
Dante Morgnanesi, Eric J. Heinrichs, Anthony R. Mele, Sean Wilkinson, Suzanne Zhou & John L. KulpIIIIII. (2015) A computational chemistry perspective on the current status and future direction of hepatitis B antiviral drug discovery. Antiviral Research 123, pages 204-215.
Crossref
YunFeng Chai & YuanJiang Pan. (2014) The effect of cation size (H+, Li+, Na+, and K+) on McLafferty-type rearrangement of even-electron ions in mass spectrometry. Science China Chemistry 57:5, pages 662-668.
Crossref
Thippani Ramesh, Pothuraju Nageswara Rao & Ramisetti Nageswara Rao. (2014) LC-MS/MS method for the characterization of the forced degradation products of Entecavir. Journal of Separation Science 37:4, pages 368-375.
Crossref
Hana Vlčková, Jaroslav Janák, Tomáš Gottvald, František Trejtnar, Petr Solich & Lucie Nováková. (2014) How to address the sample preparation of hydrophilic compounds: Determination of entecavir in plasma and plasma ultrafiltrate with novel extraction sorbents. Journal of Pharmaceutical and Biomedical Analysis 88, pages 337-344.
Crossref
Yuk-Fai Lam, Man-Fung Yuen, Wai-Kay Seto & Ching-Lung Lai. (2011) Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety. Current Hepatitis Reports 10:4, pages 235-243.
Crossref
Balasekhara Reddy Challa, Bahlul Z. Awen, Babu Rao Chandu & Shaik Rihanaparveen. (2011) LC?ESI-MS/MS method for the quantification of entecavir in human plasma and its application to bioequivalence study. Journal of Chromatography B 879:11-12, pages 769-776.
Crossref
Jia Liu, Yan Yang, Bin Hu, Zhi-yong Ma, Hong-ping Huang, Yuan Yu, Shen-pei Liu, Meng-ji Lu & Dong-liang Yang. (2010) Development of HBsAg-binding aptamers that bind HepG2.2.15 cells via HBV surface antigen. Virologica Sinica 25:1, pages 27-35.
Crossref
Michiko Shindo, Kazuaki Chayama, Satoshi Mochida, Joji Toyota, Eiichi Tomita, Hiromitsu Kumada, Osamu Yokosuka, Michio Sata, Norio Hayashi, Kazuyuki Suzuki, Takeshi Okanoue, Hirohito Tsubouchi, Hiroki Ishikawa, Taku Seriu & Masao Omata. (2009) Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial. Hepatology International 3:3, pages 445-452.
Crossref
Jing You, Hutcha Sriplung, Alan Geater, Virasakdi Chongsuvivatwong, Lin Zhuang, Yun-Li Li, Hua Lei, Jun Liu, Hong-Ying Chen, Bao-Zhang Tang & Jun-Hua Huang. (2008) Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients. BMC Infectious Diseases 8:1.
Crossref
Yi-Hsien Shih, Shiou-Hwei Yeh, Pei-Jer Chen, Wen-Pin Chou, Hurng-Yi Wang, Chun-Jen Liu, Su-Feng Lu & Ding-Shinn Chen. (2008) Hepatitis B virus Quantification and Detection of YMDD Mutants in a Single Reaction by Real-Time PCR and Annealing Curve Analysis. Antiviral Therapy 13:4, pages 469-480.
Crossref
Martin?R. Jakobsen, Hanne Arildsen, Henrik?B. Krarup, Martin Tolstrup, Lars ?stergaard & Alex?L. Laursen. (2008) Entecavir Therapy Induces de Novo HIV Reverse?Transcriptase M184V Mutation in an Antiretroviral Therapy?Naive Patient. Clinical Infectious Diseases 46:9, pages e88-e91.
Crossref
Xiao-Ling Wang, Song-Gang Xie, Ling Zhang, Wei-Xia Yang, Xing Wang & Hong-Zhi Jin. (2008) Comparison of ligase detection reaction and real-time PCR for detection of low abundant YMDD mutants in patients with chronic hepatitis B. World Journal of Gastroenterology 14:1, pages 120.
Crossref
Raffaele De Francesco & Andrea Carfí. (2007) Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Advanced Drug Delivery Reviews 59:12, pages 1242-1262.
Crossref
W.-H. Wen, W.-J. Qin, H. Gao, J. Zhao, L.-T. Jia, Q.-H. Liao, Y.-L. Meng, B.-Q. Jin, L.-B. Yao, S.-Y. Chen & A.-G. Yang. (2007) An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells. Journal of Viral Hepatitis 14:7, pages 512-519.
Crossref
Rekha Cheruvattath & Vijayan Balan. (2007) Infections in Patients With End-stage Liver Disease. Journal of Clinical Gastroenterology 41:4, pages 403-411.
Crossref
Qing He, Xiaoyan Chen & Li He. (2006) Tiopronin for chronic hepatitis B. Cochrane Database of Systematic Reviews.
Crossref
St?phanie Villet, Christian Pichoud, Jean-Pierre Villeneuve, Christian Tr?po & Fabien Zoulim. (2006) Selection of a Multiple Drug-Resistant Hepatitis B Virus Strain in a Liver-Transplanted Patient. Gastroenterology 131:4, pages 1253-1261.
Crossref
Li He, Bo Wu & Muke Zhou. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Frank W?rthner, Carsten Tschierske, Anke Kr?ger, Klaus Ditrich, Roland Pfau, Henning Priepke, Rolf Breinbauer, Hans-Achim Wagenknecht, Gerald Dr?ger, Andreas Kirschning, Norbert Sewald, Uwe Beifuss, Mathias O. Senge, Thomas J. J. M?ller, Peter R. Schreiner, Ruth Gschwind, Bernd F. Straub, Kilian Mu?iz, Martin Oestreich, J?rg Pietruszka, Thomas Lindel, Roderich S??muth, Philippe Bisel, Michael M?ller, Elmar Weinhold, Andres J?schke, Markus Albrecht, Thorsten Bach, G?tz Bucher, Heinrich Heydt & Jens Hartung. (2006) Organische Chemie 2005. Nachrichten aus der Chemie 54:3, pages 241-264.
Crossref
Zhi-Jun Yang. (2006) Comparison of amplicon-sequencing, pyrosequencing and real-time PCR for detection of YMDD mutants in patients with chronic hepatitis B. World Journal of Gastroenterology 12:44, pages 7192.
Crossref
Shridhar Hegde & Michelle Schmidt. 2006. Annual Reports in Medicinal Chemistry Volume 41. Annual Reports in Medicinal Chemistry Volume 41 439 477 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.